BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29119376)

  • 21. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells.
    Chen Q; Ganapathy S; Singh KP; Shankar S; Srivastava RK
    PLoS One; 2010 Dec; 5(12):e15288. PubMed ID: 21179458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells.
    Jin H; Sun Y; Wang S; Cheng X
    Int J Mol Sci; 2013 Jul; 14(8):16040-57. PubMed ID: 23912239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrine inhibits synovial angiogenesis in collagen-induced arthritis rats by regulating HIF-VEGF-Ang and inhibiting the PI3K/Akt signaling pathway.
    Ao L; Gao H; Jia L; Liu S; Guo J; Liu B; Dong Q
    Mol Immunol; 2022 Jan; 141():13-20. PubMed ID: 34781187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrine alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of PI3K/Akt-mediated NF-κB inhibition and Keap1/Nrf2-dependent HO-1 inductionn.
    Liu X; Zhang X; Ma K; Zhang R; Hou P; Sun B; Yuan S; Wang Z; Liu Z
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):38-44. PubMed ID: 27755950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer.
    Li Q; Xu J; He Z; Wen X; Wang F; Zhang P; Li J; Song B; Wang Q; Li R; Huang H
    Cancer Manag Res; 2019; 11():10125-10133. PubMed ID: 31819645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrine exerts anti‑breast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF‑7 cells.
    Du J; Li J; Song D; Li Q; Li L; Li B; Li L
    Mol Med Rep; 2020 Nov; 22(5):3659-3666. PubMed ID: 33000249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways.
    Zhou S; Dai Z; Wang L; Gao X; Yang L; Wang Z; Wang Q; Liu Z
    J Cell Mol Med; 2021 Dec; 25(24):11157-11169. PubMed ID: 34761497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway.
    Zhang S; Cheng B; Li H; Xu W; Zhai B; Pan S; Wang L; Liu M; Sun X
    Mol Biol Rep; 2014; 41(4):2101-8. PubMed ID: 24452711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effects of pollen polysaccharides from Chinese wolfberry on DU145 cells via the PI3K/AKT pathway in vitro and in vivo.
    Ran L; Chen F; Zhang J; Mi J; Lu L; Yan Y; Cao Y
    Int J Biol Macromol; 2020 Jun; 152():1164-1173. PubMed ID: 31765754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrine inhibits the invasive properties of human glioma cells by regulating epithelial‑to‑mesenchymal transition.
    Wang Z; Wu Y; Wang Y; Jin Y; Ma X; Zhang Y; Ren H
    Mol Med Rep; 2015 May; 11(5):3682-6. PubMed ID: 25572156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Matrine as a Novel Regulator of the CXCR4 Signaling Axis in Tumor Cells.
    Jung YY; Um JY; Narula AS; Namjoshi OA; Blough BE; Kumar AP; Ahn KS
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
    Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
    Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice.
    Shukla S; Bhaskaran N; Maclennan GT; Gupta S
    Prostate; 2013 Oct; 73(14):1507-17. PubMed ID: 23765843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
    Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT
    Sun Y; Jia X; Hou L; Liu X; Gao Q
    Lipids Health Dis; 2017 Mar; 16(1):59. PubMed ID: 28330470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo.
    Thomas C; Lamoureux F; Crafter C; Davies BR; Beraldi E; Fazli L; Kim S; Thaper D; Gleave ME; Zoubeidi A
    Mol Cancer Ther; 2013 Nov; 12(11):2342-55. PubMed ID: 23966621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway.
    Xu GP; Zhao W; Zhuang JP; Zu JN; Wang DY; Han F; Zhang ZP; Yan JL
    Tumour Biol; 2015 Mar; 36(3):1653-9. PubMed ID: 25371071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.